The utilization of antidepressants - a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994

Acta Psychiatrica Scandinavica

Volumn 96, Issue 2, 1997, Pages 94-100

  Isacsson, G ^a   Holmgren, P ^b   Druid, H ^b   Bergman, U ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b National Board of Forensic Medicine   (Sweden)

Author keywords

Antidepressants; SSRIs; Suicide; Toxicity

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUVOXAMINE; MIANSERIN; MOCLOBEMIDE; TRIMIPRAMINE;

ARTICLE; DRUG EFFICACY; DRUG EXPOSURE; DRUG UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; SUICIDE; SWEDEN; TREATMENT FAILURE;

EID: 0030806209     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09912.x     Document Type: Article

References (35)

1. ISACSSON G, BERGMAN U, RICH CL. Antidepressants, depression, and suicide: An analysis of the San Diego Study. J Affect Disord 1994: 32: 277-286.
2. CHENG ATA. Mental illness and suicide. Arch Gen Psychiatry 1995: 52: 594-603.
3. EDWARDS JG. Suicide and antidepressants. Controversies on prevention, provocation and self-poisoning continue. Br Med J 1995: 310: 205-206.
4. ISACSSON G, HOLMGREN P, WASSERMAN D, BERGMAN U. Use of antidepressants among people committing suicide in Sweden. Br Med J 1994: 308: 506-509.
5. GRAM LF, ISACSSON G, BERGMAN U. Moclobemide (letter). Lancet 1994: 343: 679-680.
6. EKLUND A, JONSSON J, SCHUBERT J. A procedure for simultaneous screening and quantification of basic drugs in liver, utilizing capillary gas chromatography and nitrogen-sensitive detection. J Anal Toxicology 1983: 7: 24-28.
7. HANZLICK RL. Postmortem blood concentrations of parent tricyclic antidepressant (TCA) drugs in 11 cases of suicide. Am J Forens Med Pathology 1984: 5: 11-13.
8. DRUID H, HOLMGREN P. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forens Sci 1997: 42: 79-87.
9. WESSLING A, BERGMAN U, WESTERHOLM B. On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacology 1991: 40: 495-500.
10. GUESS HA, LYDICK EG, SMALL RD, MILLER LP Epidemiological programs for computers and calculators/ Exact binomial confidence intervals for the relative risk in follow-up studies with sparsely stratified incidence density data. Am J Epidemiology 1987: 125: 340-347.
11. KESSLER RC, MCGONAGLE KA, ZHAO S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States; results from the National Comorbidity Survey. Arch Gen Psychiatry 1994: 51: 8-19.
12. LI WAN PO A. Fluoxetine and suicide: meta-analysis and Monte-Carlo simulations. Pharmacoepidemiol Drug Safety 1993: 2: 79-84.
13. ISACSSON G, REDFORS I, WASSERMAN D, BERGMAN U. Choice of antidepressants: a questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. Br Med J 1994: 309: 1546-1549.
14. DERBY LE, JICK H, DEAN AD. Antidepressant drugs and suicide. J Clin Psychopharmacology 1992: 12: 235-240.
15. JICK SS, DEAN AD, JICK H. Antidepressants and suicide. Br Med J 1995: 310: 215-218.
16. DANISH UNIVERITY ANTIDEPRESSANT GROUP. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 1986: 90: 131-138.
17. DANISH UNIVERITY ANTIDEPRESSANT GROUP. Moclobemide: a reversible MAO-A inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1993: 28: 105-116.
18. DANISH UNIVERITY ANTIDEPRESSANT GROUP. Paroxetine: a selective reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990: 18: 289-299.
19. ROOSE SP, GLASSMAN AH, ATTIA E, WOODRING S. Comparative efficacy of the specific serotonin reuptake inhibitors and the tricyclics in the treatment of melancholia. Am J Psychiatry 1994: 151: 1735-1739.
20. ISACSSON G, BOËTHIUS G, BERGMAN U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand 1992: 85: 444-448.
21. ISACSSON G, BERGMAN U, RICH CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996: 41: 1-8.
22. ISACSSON G, WASSERMAN D, BERGMAN U. Self-poisonings with antidepressants and other psychotropics in an urban area of Sweden. Ann Clin Psychiatry 1995: 7: 113-118.
23. RUTZ W, VON KNORRING L, WÅLINDER J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr Scand 1989: 80: 151-154.
24. ISACSSON G. Depression, antidepressants and suicide. A study of the role of antidepressants in the prevention of suicide PhD thesis, Karolinska Institute, Huddinge, 1994.
25. ISOMETSA ET, HENRIKSSON MM, ARO HM, HEIKKINEN ME, KUOPPASALMI KI, LÖNNQVIST JK. Suicide in major depression. Am J Psychiatry 1994: 151: 530-536.
26. KELLEHER MJ, DALY M, KELLEHER MJA. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br J Psychiatry 1992: 161: 625-628.
27. ISACSSON G, BERGMAN U. Risks with citalopram in perspective (letter). Lancet 1996: 348: 1033.
28. GRAM LF, KRAGH-SØRENSEN P, ISACSSON G, BERGMAN U. Study did not consider treatment efficacy (letter). Br Med J 1995: 311: 55-56.
29. ISACSSON G, HOLMGREN P, WASSERMAN D, BERGMAN U. Suicide and the use of antidepressants. Authors' reply (letter). Br Med J 1994: 308: 916.
30. ISACSSON G, HOLMGREN P, WASSERMAN D, BERGMAN U. Antidepressants and suicide (letter). Br Med J 1995: 310: 127.
31. BARRACLOUGH BM, PALLIS DJ. Depression followed by suicide: a comparison of depressed suicides with living depressives. Psychol Med 1975: 5: 55-61.
32. HENRY JA, ALEXANDER CA, SENER EK. Relative mortality from overdose of antidepressants. Br Med J 1995: 310: 221-224.
33. GRAM LF. Fluoxetine, N Engl J Med 1994: 331: 1354-1361.
34. GLASSMAN AH. Antidepressant plasma levels revisited. Int Clin Psychopharmacology 1994: 9 (Suppl. 2): 25-30.
35. JONSSON B, BEBBINGTON PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994: 164: 665-673.